Studies have demonstrated that monitoring POSTN for predicting distant metastasis in breast cancer performs comparably to CA153, suggesting that POSTN can serve as a novel biomarker to complement CEA and CA153 in predicting BCBM [192]. Here, CEACAM5 is linked to breast carcinoma.